Matches in SemOpenAlex for { <https://semopenalex.org/work/W2613990790> ?p ?o ?g. }
Showing items 1 to 99 of
99
with 100 items per page.
- W2613990790 endingPage "893" @default.
- W2613990790 startingPage "888" @default.
- W2613990790 abstract "Background The completion of continuing professional development (CPD) is mandatory for medical oncologists and trainees (MO&T). Pharmaceutical companies may fund some CPD activities, but there is increasing debate about the potential for conflicts of interest (COI). Aim To assess current practices around funding to attend CPD activities. Methods An electronic survey was distributed to Australian MO&T. The survey asked questions about current practices, institutional policies and perceptions about attending CPD funded by pharmaceutical companies. The design looked at comparing responses between MO&T as well as their understanding of and training around institutional and ethical process. Results A total of 157 of 653 (24%) responses was received, the majority from MO (76%). Most CPD activities attended by MO&T were self-funded (53%), followed by funding from institutions (19%), pharmaceutical companies (16%) and salary award (16%). Most institutions allowed MO&T to receive CPD funding from professional organisations (104/157, 66%) or pharmaceutical companies (90/157, 57%). A minority of respondents (13/157, 8%) reported that the process to use pharmaceutical funds had been considered by an ethics committee. Although 103/157 (66%) had received pharmaceutical funding for CPD, most (109/157, 69%) reported never receiving training about potential COI. The lack of education was more noticeable among trainees (odds ratio (OR) 8.61, P = 0.02). MO&T acknowledged the potential bias towards a pharmaceutical product (P = 0.05) but believed there was adequate separation between themselves and pharmaceutical companies (P < 0.01). Conclusion Majority of CPD attended by MO&T is self-funded. There is lack of clarity in institutional policies regarding external funding support for CPD activities. Formal education about potential COI is lacking." @default.
- W2613990790 created "2017-05-19" @default.
- W2613990790 creator A5020314758 @default.
- W2613990790 creator A5046503557 @default.
- W2613990790 creator A5054097874 @default.
- W2613990790 creator A5056048160 @default.
- W2613990790 creator A5062978331 @default.
- W2613990790 creator A5063000325 @default.
- W2613990790 creator A5068920626 @default.
- W2613990790 creator A5078365633 @default.
- W2613990790 creator A5079833339 @default.
- W2613990790 date "2017-08-01" @default.
- W2613990790 modified "2023-09-27" @default.
- W2613990790 title "Survey of practices around pharmaceutical company funding for continuing professional development among medical oncologists and trainees in Australia" @default.
- W2613990790 cites W1659574006 @default.
- W2613990790 cites W1964644957 @default.
- W2613990790 cites W1992945952 @default.
- W2613990790 cites W2037296375 @default.
- W2613990790 cites W2058605372 @default.
- W2613990790 cites W2087897456 @default.
- W2613990790 cites W2147159810 @default.
- W2613990790 cites W2171169690 @default.
- W2613990790 cites W2415064147 @default.
- W2613990790 doi "https://doi.org/10.1111/imj.13482" @default.
- W2613990790 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28485058" @default.
- W2613990790 hasPublicationYear "2017" @default.
- W2613990790 type Work @default.
- W2613990790 sameAs 2613990790 @default.
- W2613990790 citedByCount "8" @default.
- W2613990790 countsByYear W26139907902017 @default.
- W2613990790 countsByYear W26139907902018 @default.
- W2613990790 countsByYear W26139907902020 @default.
- W2613990790 countsByYear W26139907902021 @default.
- W2613990790 countsByYear W26139907902022 @default.
- W2613990790 countsByYear W26139907902023 @default.
- W2613990790 crossrefType "journal-article" @default.
- W2613990790 hasAuthorship W2613990790A5020314758 @default.
- W2613990790 hasAuthorship W2613990790A5046503557 @default.
- W2613990790 hasAuthorship W2613990790A5054097874 @default.
- W2613990790 hasAuthorship W2613990790A5056048160 @default.
- W2613990790 hasAuthorship W2613990790A5062978331 @default.
- W2613990790 hasAuthorship W2613990790A5063000325 @default.
- W2613990790 hasAuthorship W2613990790A5068920626 @default.
- W2613990790 hasAuthorship W2613990790A5078365633 @default.
- W2613990790 hasAuthorship W2613990790A5079833339 @default.
- W2613990790 hasBestOaLocation W26139907902 @default.
- W2613990790 hasConcept C10138342 @default.
- W2613990790 hasConcept C134215751 @default.
- W2613990790 hasConcept C144133560 @default.
- W2613990790 hasConcept C17744445 @default.
- W2613990790 hasConcept C199539241 @default.
- W2613990790 hasConcept C2777276634 @default.
- W2613990790 hasConcept C2777280699 @default.
- W2613990790 hasConcept C2779652045 @default.
- W2613990790 hasConcept C2780090960 @default.
- W2613990790 hasConcept C2988064887 @default.
- W2613990790 hasConcept C39549134 @default.
- W2613990790 hasConcept C509550671 @default.
- W2613990790 hasConcept C512399662 @default.
- W2613990790 hasConcept C71924100 @default.
- W2613990790 hasConcept C98274493 @default.
- W2613990790 hasConceptScore W2613990790C10138342 @default.
- W2613990790 hasConceptScore W2613990790C134215751 @default.
- W2613990790 hasConceptScore W2613990790C144133560 @default.
- W2613990790 hasConceptScore W2613990790C17744445 @default.
- W2613990790 hasConceptScore W2613990790C199539241 @default.
- W2613990790 hasConceptScore W2613990790C2777276634 @default.
- W2613990790 hasConceptScore W2613990790C2777280699 @default.
- W2613990790 hasConceptScore W2613990790C2779652045 @default.
- W2613990790 hasConceptScore W2613990790C2780090960 @default.
- W2613990790 hasConceptScore W2613990790C2988064887 @default.
- W2613990790 hasConceptScore W2613990790C39549134 @default.
- W2613990790 hasConceptScore W2613990790C509550671 @default.
- W2613990790 hasConceptScore W2613990790C512399662 @default.
- W2613990790 hasConceptScore W2613990790C71924100 @default.
- W2613990790 hasConceptScore W2613990790C98274493 @default.
- W2613990790 hasIssue "8" @default.
- W2613990790 hasLocation W26139907901 @default.
- W2613990790 hasLocation W26139907902 @default.
- W2613990790 hasLocation W26139907903 @default.
- W2613990790 hasOpenAccess W2613990790 @default.
- W2613990790 hasPrimaryLocation W26139907901 @default.
- W2613990790 hasRelatedWork W1999055250 @default.
- W2613990790 hasRelatedWork W2019836034 @default.
- W2613990790 hasRelatedWork W2023808680 @default.
- W2613990790 hasRelatedWork W2028648528 @default.
- W2613990790 hasRelatedWork W2056608341 @default.
- W2613990790 hasRelatedWork W2354630334 @default.
- W2613990790 hasRelatedWork W2464836013 @default.
- W2613990790 hasRelatedWork W2613990790 @default.
- W2613990790 hasRelatedWork W78016330 @default.
- W2613990790 hasRelatedWork W2470533525 @default.
- W2613990790 hasVolume "47" @default.
- W2613990790 isParatext "false" @default.
- W2613990790 isRetracted "false" @default.
- W2613990790 magId "2613990790" @default.
- W2613990790 workType "article" @default.